GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Suzuken Co 9987.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,857

+2.00%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥2.49trn

FY2017FY2026

Net income

¥38.14bn

FY2017FY2026

Free cash flow

¥18.50bn

FY2017FY2026

Shareholders' equity

¥415.88bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥2.49trn¥2.40trn¥2.39trn¥2.31trn¥2.24trn¥2.13trn¥2.21trn¥2.13trn¥2.12trn¥2.13trn
Gross profit¥192.53bn¥192.23bn¥185.25bn¥179.69bn¥167.33bn¥157.84bn¥194.12bn¥189.29bn¥187.51bn¥193.22bn
Research and development—¥3.52bn¥3.28bn¥2.95bn¥4.59bn¥3.45bn¥4.65bn¥5.87bn¥6.67bn¥7.64bn
Operating income¥36.38bn¥37.13bn¥34.88bn¥32.61bn¥20.12bn¥9.16bn¥32.57bn¥27.23bn¥19.74bn¥18.71bn
Net income¥38.14bn¥34.50bn¥29.02bn¥20.34bn¥14.39bn¥7.90bn¥28.21bn¥30.20bn¥18.82bn¥21.31bn
Diluted earnings per share566.56494.21383.25251.07167.5589.79316.28331.41199.93225.03

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥1.16trn¥1.11trn¥1.23trn¥1.15trn¥1.14trn¥1.11trn¥1.11trn¥1.19trn¥1.17trn¥1.11trn
Cash and short-term investments¥141.67bn¥141.58bn¥242.11bn¥192.70bn¥201.46bn¥212.12bn¥211.63bn¥264.88bn¥236.67bn¥140.44bn
Total liabilities¥739.75bn¥706.41bn¥812.26bn¥734.57bn¥723.65bn¥696.51bn¥699.80bn¥787.61bn¥766.90bn¥712.51bn
Debt—¥1.80bn¥1.80bn¥1.80bn¥1.88bn¥2.28bn¥2.57bn¥2.54bn¥2.75bn¥2.86bn
Shareholders' equity¥415.88bn¥407.29bn¥416.31bn¥411.21bn¥417.69bn¥417.05bn¥411.84bn¥400.77bn¥405.75bn¥395.94bn
Shares outstanding67m70m76m81m86m88m89m91m94m95m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥33.57bn−¥65.08bn¥87.22bn¥37.27bn¥9.52bn¥15.60bn−¥25.82bn¥41.75bn¥98.07bn¥27.01bn
Capital spending−¥15.06bn−¥14.31bn−¥10.81bn−¥17.74bn−¥14.29bn−¥7.86bn−¥11.70bn−¥5.80bn−¥5.50bn−¥10.29bn
Free cash flow¥18.50bn−¥79.39bn¥76.41bn¥19.53bn−¥4.77bn¥7.74bn−¥37.52bn¥35.95bn¥92.56bn¥16.73bn
Dividends paid−¥7.09bn−¥6.99bn−¥6.29bn−¥6.33bn−¥6.38bn−¥6.78bn−¥6.75bn−¥6.06bn−¥5.17bn−¥6.84bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥628.96bn¥601.02bn¥666.19bn¥626.57bn¥592.87bn¥561.28bn¥641.35bn¥615.13bn
Gross profit¥43.35bn¥47.93bn¥50.98bn¥50.34bn¥43.27bn¥45.52bn¥52.13bn¥51.27bn
Operating income¥4.19bn¥9.14bn¥10.27bn¥11.37bn¥5.59bn¥7.33bn¥12.70bn¥11.80bn
Net income¥3.38bn¥7.12bn¥14.77bn¥12.46bn¥3.78bn¥3.82bn¥10.39bn¥15.32bn
Diluted earnings per share50.23105.79211.66178.4954.1854.78137.29202.32
Total assets¥1.20trn¥1.16trn¥1.31trn¥1.17trn¥1.15trn¥1.11trn¥1.30trn¥1.22trn
Cash and short-term investments¥148.78bn¥141.67bn¥218.70bn¥148.28bn¥142.20bn¥141.58bn¥205.53bn¥184.52bn
Debt—————¥235.0m——
Shareholders' equity¥415.70bn¥415.88bn¥405.08bn¥405.50bn¥402.16bn¥407.29bn¥413.63bn¥429.74bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.4%3.2%1.1%
Operating income3.7%31.8%2.6%
Net income23.3%37.0%2.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin7.9%7.8%7.7%8.2%
Operating margin1.5%1.5%1.2%1.2%
Net margin1.5%1.3%1.0%1.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings5.36.26.29.310.718.55.96.714.010.3
Price to sales0.10.10.10.10.10.10.10.10.10.1

Dividends and splits

Per share, in the currency the company pays

Paid for 28 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year60.0075.0045.0038.0036.0036.0038.0037.00
  • 1.1-for-1 split · 27 Mar 2015
  • 1.2-for-1 split · 26 Mar 2004
  • 1.1-for-1 split · 26 Mar 1997
  • 1.1-for-1 split · 26 Mar 1996
  • 1.5-for-1 split · 28 Mar 1995

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.